AVE 25.0% 0.3¢ avecho biotechnology limited

banti's presentation, page-19

  1. 379 Posts.
    Having originated this particular thread with a splenetic reaction to Banti's presentation may I
    (a) compliment Ferdie on having the sense /balls(me lacking)to speak to Banti's face and
    (b) commend Banti's answer.

    My guess remains they will run out of cash before they have an irresistibly saleable offering and Elixia is a romantic distraction that by bleeding cash will cut the chances of success even more. Equally, the non take-up of the rights by any execs. was a disgrace.

    But nonetheless an answer to which you couldn't fail to respond sympathetically.
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.